Matricelf Ltd. (MTLF.TA)
Matricelf Ltd. operates in the Biotechnology industry of the Healthcare sector, headquartered in Ness Ziona, HM, IL. The stock last traded at $259.60, up 3.51% on the session, giving a market capitalisation of $78.7M. Its beta of 0.32 implies it has historically moved less than the broad market.
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company’s regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson’s disease, and myocardial infarction, as well as for 3D bioprinting. The company has a strategic collaboration with Sheba Medical Center for the development and clinical advancement of its neural tissue implant product for the treatment of spinal cord injury. The company has a strategic collaboration with CiRA Foundation for the development of regenerative manufacturing technologies and the evaluation of iPSC-based neural tissue engineering for therapeutic applications. The company was incorporated in 2019 and is based in Ness Ziona, Israel.
Matricelf Ltd. is most often compared with the following Healthcare names: